Background Background There has been
There has been controversy as to whether early controversy as to whether early intervention in psychosis can improve the intervention in psychosis can improve the outcome of the disorder. outcome of the disorder.
Aims Aims To establish if there is an
To establish if there is an association between duration of association between duration of untreated psychosis and the 4-year untreated psychosis and the 4-year outcome of persons with a first episode of outcome of persons with a first episode of psychosis. psychosis.
Method Method Prospective naturalistic
Prospective naturalistic follow-up study of the outcome of follow-up study of the outcome of consecutive first presentations with consecutive first presentations with DSM^IV psychosis attending a DSM^IV psychosis attending a community-based psychiatric service. community-based psychiatric service.
Results
Results A longer duration of untreated A longer duration of untreated psychosis was associated with a psychosis was associated with a significantly poorer functional and significantly poorer functional and symptomatic outcome 4 years later.For symptomatic outcome 4 years later. For schizophrenia and schizophreniform schizophrenia and schizophreniform disorder, each increment in duration of disorder, each increment in duration of untreated psychosis was associated with a untreated psychosis was associated with a 7.8 pointdecrease in global functioning and 7.8 pointdecreasein global functioningand an increase in positive symptoms scores by an increase in positive symptoms scores by 1.9 points. 1.9 points.
Conclusions Conclusions This study extends the
This study extends the findings of short-term follow-up studies by findings of short-term follow-up studies by confirming an association between confirming an association between duration of untreated psychosis and 'midduration of untreated psychosis and 'midterm'outcome. term' outcome. Although early intervention is well estabAlthough early intervention is well established in numerous branches of medicine, lished in numerous branches of medicine, the extent to which this might extend to the extent to which this might extend to psychotic illness has engendered conpsychotic illness has engendered considerable controversy. The uncertainty siderable controversy. The uncertainty surrounding this issue may reflect the insurrounding this issue may reflect the inconsistent findings of studies and also the consistent findings of studies and also the question whether the link demonstrated question whether the link demonstrated between duration of untreated psychosis between duration of untreated psychosis and short-term outcome is sustained in the and short-term outcome is sustained in the long term (Carbone long term (Carbone et al et al, 1999; Robinson , 1999; Robinson et al et al, 1999; Marshall & Lockwood, , 1999; Marshall & Lockwood, 2004) . Inconsistencies between studies 2004). Inconsistencies between studies may be explained by methodological artemay be explained by methodological artefacts such as sampling differences, diagnosfacts such as sampling differences, diagnostic heterogeneity and varying concepts of tic heterogeneity and varying concepts of outcome. In this study we address these outcome. In this study we address these issues by following up a representative issues by following up a representative sample of individuals with a first episode sample of individuals with a first episode of psychosis, and assessing whether the of psychosis, and assessing whether the duration of untreated psychosis is indeduration of untreated psychosis is independently associated with pathological pendently associated with pathological and functional outcome 4 years after and functional outcome 4 years after presentation. presentation.
Declaration of interest

METHOD METHOD Population Population
The sample consisted of the 171 persons The sample consisted of the 171 persons resident in a South Dublin urban catchment resident in a South Dublin urban catchment area of 165 000 who, between 1995 and area of 165 000 who, between 1995 and 1999, had experienced a first psychotic epi-1999, had experienced a first psychotic episode and had presented either to Cluain sode and had presented either to Cluain Mhuire Family Centre, which provides the Mhuire Family Centre, which provides the public psychiatric service to the catchment public psychiatric service to the catchment area, or to St John of God Hospital, which area, or to St John of God Hospital, which provides care to persons from the catchprovides care to persons from the catchment area and elsewhere. First-episode ment area and elsewhere. First-episode psychosis was defined as first lifetime psychosis was defined as first lifetime presentation to any psychiatric service with presentation to any psychiatric service with a psychotic episode, including mania, a psychotic episode, including mania, among all adolescents (12 years of age or among all adolescents (12 years of age or over) and adults (no upper age limit). If over) and adults (no upper age limit). If neuroleptic medication had been prescribed neuroleptic medication had been prescribed before presentation, for example by a before presentation, for example by a family practitioner, patients were incepted family practitioner, patients were incepted provided they had not been receiving provided they had not been receiving medication for more than 30 days before medication for more than 30 days before referral to the service (Browne referral to the service (Browne et al et al, , 2000) . At the time of the study there were 2000). At the time of the study there were no early detection strategies in place. no early detection strategies in place. Following approval by the Research Ethics Following approval by the Research Ethics Committee of St John of God Hospital, all Committee of St John of God Hospital, all those approached gave verbal consent to those approached gave verbal consent to their participation in the study. their participation in the study.
Assessments Assessments
At presentation, we assessed psychopathoAt presentation, we assessed psychopathology using the Positive and Negative logy using the Positive and Negative Syndrome Scale (PANSS; Kay Syndrome Scale (PANSS; Kay et al et al, 1986) , 1986) and global functioning using the Global and global functioning using the Global Assessment of Function scale (GAF; First Assessment of Function scale (GAF; First et al et al, 1995) . When clinically stable, we used , 1995). When clinically stable, we used the Structured Clinical Interview for DSM the Structured Clinical Interview for DSM (SCID) to ascertain DSM-IV Axis I diag-(SCID) to ascertain DSM-IV Axis I diagnoses (American Psychiatric Association, noses (American Psychiatric Association, 1994); socio-demographic information 1994); socio-demographic information was also recorded. During the course of was also recorded. During the course of the SCID I interview, participants dated, the SCID I interview, participants dated, to the nearest month, their first experience to the nearest month, their first experience of the onset of psychotic symptom(s); they of the onset of psychotic symptom(s); they detailed all previous contacts with the detailed all previous contacts with the health services, police and judiciary, and health services, police and judiciary, and any treatment received during the prodroany treatment received during the prodromal and/or psychotic phases. Their consent mal and/or psychotic phases. Their consent was then sought to interview their parent(s) was then sought to interview their parent(s) or nearest (geographically) living adult relaor nearest (geographically) living adult relative. Where possible, we requested that tive. Where possible, we requested that either both parents or at least two family either both parents or at least two family members should attend. In this interview, members should attend. In this interview, supplementary information on premorbid, supplementary information on premorbid, prodromal and onset phases of the illness prodromal and onset phases of the illness was collected. We assessed functioning over was collected. We assessed functioning over the premorbid period using the Premorbid the premorbid period using the Premorbid Social Adjustment (PSA) scale (Foerster Social Adjustment (PSA) scale (Foerster et et al al, 1991) , which addresses the patient's pre-, 1991), which addresses the patient's premorbid functioning over two distinct time morbid functioning over two distinct time periods: between 5 and 11 years of age periods: between 5 and 11 years of age (PSA1) and between 12 and 16 years of (PSA1) and between 12 and 16 years of age (PSA2). To increase the validity of preage (PSA2). To increase the validity of premorbid data, we used only objective meamorbid data, we used only objective measures of premorbid functioning given by a sures of premorbid functioning given by a parent or an older relative with an adequate parent or an older relative with an adequate knowledge of the patient during this time. knowledge of the patient during this time. Furthermore, as some participants experiFurthermore, as some participants experienced the onset of psychotic or prodromal enced the onset of psychotic or prodromal symptoms during the PSA2 time period, symptoms during the PSA2 time period, we used only PSA1 scores in analyses. we used only PSA1 scores in analyses.
In the family interview, we evaluated In the family interview, we evaluated the emergence of different phases of illness the emergence of different phases of illness using the scale of Beiser and colleagues using the scale of Beiser and colleagues (Beiser (Beiser et al et al, 1993) . Duration of untreated , 1993) . Duration of untreated psychosis was defined as the interval psychosis was defined as the interval between first noted psychotic symptom(s) between first noted psychotic symptom(s) and presentation to the psychiatric services and presentation to the psychiatric services for initiation of adequate treatment of a for initiation of adequate treatment of a psychotic illness; first manic symptom(s) psychotic illness; first manic symptom(s) were used for bipolar disorder. This figure were used for bipolar disorder. This figure was based on independent parental or relawas based on independent parental or relative and participant interviews; in instances tive and participant interviews; in instances where there was discrepancy between these where there was discrepancy between these two figures, or where there was no infortwo figures, or where there was no information available from a relative, we mation available from a relative, we assigned a consensus duration using all assigned a consensus duration using all available sources of information. Onset of available sources of information. Onset of the prodrome was defined as earliest noted the prodrome was defined as earliest noted deviation from the person's premorbid deviation from the person's premorbid functioning or emergence of prodromal functioning or emergence of prodromal symptoms as defined in the Beiser scale secsymptoms as defined in the Beiser scale sections: attitude/thinking, mood, behaviour/ tions: attitude/thinking, mood, behaviour/ performance and somatic symptoms. The performance and somatic symptoms. The duration of prodrome was defined as time duration of prodrome was defined as time between onset of prodromal symptoms between onset of prodromal symptoms and the onset of first psychotic symptom(s); and the onset of first psychotic symptom(s); this value, when added to duration of this value, when added to duration of untreated psychosis, gave duration of untreated psychosis, gave duration of untreated illness. untreated illness.
At 4 years following inception, all At 4 years following inception, all participants were contacted and invited to participants were contacted and invited to return for follow-up assessment. During return for follow-up assessment. During these interviews, psychopathology and these interviews, psychopathology and global functioning were assessed as above global functioning were assessed as above by an investigator masked to initial scores by an investigator masked to initial scores and to duration of untreated psychosis. and to duration of untreated psychosis.
Statistical analysis Statistical analysis
For outcome analyses, remission was deFor outcome analyses, remission was defined fined as no score higher than 3 over the as no score higher than 3 over the previous month on any PANSS item at previous month on any PANSS item at follow-up (Larsen follow-up (Larsen et al et al, 2000) . Paired , 2000). Paired t t-tests -tests were used to compare scores at presentawere used to compare scores at presentation with those at 4-year follow-up. We tion with those at 4-year follow-up. We examined the relationship between variexamined the relationship between variables (duration of untreated psychosis, ables (duration of untreated psychosis, prodrome, gender, years in education, age prodrome, gender, years in education, age at onset of psychotic symptoms, PSA1 at onset of psychotic symptoms, PSA1 score) and outcome dimensions using correscore) and outcome dimensions using correlation analyses. We then used stepwise lation analyses. We then used stepwise multiple logistic and linear regression promultiple logistic and linear regression procedures to ascertain whether duration of cedures to ascertain whether duration of untreated psychosis was associated with untreated psychosis was associated with outcome independent of other significant outcome independent of other significant variables. In these analyses, we controlled variables. In these analyses, we controlled for scores at presentation and factors for scores at presentation and factors known to influence duration of untreated known to influence duration of untreated psychosis at presentation (diagnosis and psychosis at presentation (diagnosis and social withdrawal). The relationship social withdrawal). The relationship between duration measured as a binary between duration measured as a binary variable, split at the median score, and variable, split at the median score, and other variables was assessed using Cohen's other variables was assessed using Cohen's effect sizes (Cohen, 1969) . We repeated effect sizes (Cohen, 1969) . We repeated the outcome analyses confining the group the outcome analyses confining the group to those with a diagnosis of schizophrenia to those with a diagnosis of schizophrenia or schizophreniform disorder. or schizophreniform disorder.
We evaluated interrater reliabilities for We evaluated interrater reliabilities for the PANSS by the concurrent examination the PANSS by the concurrent examination of 10 patients with chronic schizophrenia. of 10 patients with chronic schizophrenia. We rated family interviews in patients with We rated family interviews in patients with first-episode psychosis to assess interrater first-episode psychosis to assess interrater reliabilities for the PSA and the dating of reliabilities for the PSA and the dating of the onset of psychotic symptoms. the onset of psychotic symptoms.
RESULTS RESULTS
Interrater reliabilities Interrater reliabilities
The intraclass correlation coefficients The intraclass correlation coefficients between raters were as follows: PANSS between raters were as follows: PANSS positive subscale ( positive subscale (r r¼0.94), PANSS negative 0.94), PANSS negative subscale ( subscale (r r¼0.73), PANSS total score 0.73), PANSS total score ( (r r¼0.88), PSA2 ( 0.88), PSA2 (r r¼0.92), duration of 0.92), duration of untreated psychosis ( untreated psychosis (r r¼0.94). 0.94).
Participants' characteristics Participants' characteristics at presentation at presentation
The sample consisted of 171 consecutive The sample consisted of 171 consecutive presentations to the clinical services with presentations to the clinical services with a first episode of psychosis. All patients a first episode of psychosis. All patients completed initial clinical assessment completed initial clinical assessment (PANSS and SCID), but 22 refused consent (PANSS and SCID), but 22 refused consent to contact a relative. Participants were preto contact a relative. Participants were predominantly male (99, 58%), single (146, dominantly male (99, 58%), single (146, 85.4%) and living in the family home 85.4%) and living in the family home (137, 80.1%). The mean age at presenta-(137, 80.1%). The mean age at presentation was 28.5 years (s.d. tion was 28.5 years (s.d.¼11.1). At 11.1). At presentation, 101 (59.1%) met DSM-IV presentation, 101 (59.1%) met DSM-IV criteria for schizophrenia or schizophrenicriteria for schizophrenia or schizophreniform disorder, 13 (7.6%) for delusional disform disorder, 13 (7.6%) for delusional disorder, 25 (14.6%) for bipolar disorder on order, 25 (14.6%) for bipolar disorder on the basis of a first episode of manic sympthe basis of a first episode of manic symptoms, 11 (6.4%) for major depressive distoms, 11 (6.4%) for major depressive disorder with a first episode of psychotic order with a first episode of psychotic features, 12 (7.0%) for substance-induced features, 12 (7.0%) for substance-induced psychosis, 5 (2.9%) for psychosis owing psychosis, 5 (2.9%) for psychosis owing to a general medical condition and 4 to a general medical condition and 4 (2.3%) psychosis not otherwise specified. (2.3%) psychosis not otherwise specified. No cases of schizoaffective disorder or brief No cases of schizoaffective disorder or brief psychotic disorder were encountered. The psychotic disorder were encountered. The majority, 144 (84.2%) were treated initimajority, 144 (84.2%) were treated initially as in-patients. For subsequent analyses, ally as in-patients. For subsequent analyses, patients with a diagnosis of psychosis patients with a diagnosis of psychosis owing to a general medical condition were owing to a general medical condition were excluded, leaving 166 participants. excluded, leaving 166 participants.
Premorbid adjustment scores were unPremorbid adjustment scores were unavailable for 38 of the total group (parents available for 38 of the total group (parents deceased or permission to contact them deceased or permission to contact them refused) including 11 of the group with refused) including 11 of the group with schizophrenia. schizophrenia. 
Duration of untreated psychosis
Follow-up at 4 years Follow-up at 4 years
Of the 166 participants, 132 (79.5%) conOf the 166 participants, 132 (79.5%) consented to a second direct interview and sented to a second direct interview and assessment 4 years after presentation; 4 assessment 4 years after presentation; 4 (2.4%) had died by suicide and 30 (2.4%) had died by suicide and 30 (18.1%) refused follow-up assessment or (18.1%) refused follow-up assessment or were untraceable. There were no significant were untraceable. There were no significant differences between those who participated differences between those who participated in follow-up and those who did not in terms in follow-up and those who did not in terms of duration of untreated psychosis, length of duration of untreated psychosis, length of prodrome, years in education, premorbid of prodrome, years in education, premorbid social adjustment, gender, age, psychosocial adjustment, gender, age, psychopathology or global functioning at pathology or global functioning at presentation, either within the overall presentation, either within the overall group or among those with a diagnosis group or among those with a diagnosis of schizophrenia or schizophreniform of schizophrenia or schizophreniform disorder. disorder.
PANSS data were available for 129 of PANSS data were available for 129 of the 132 participants and, of these, 76 the 132 participants and, of these, 76 (57.6% of 132) had no score higher than (57.6% of 132) had no score higher than 3 for any PANSS item at 4-year follow-up 3 for any PANSS item at 4-year follow-up and were therefore defined as in remission and were therefore defined as in remission (Larsen (Larsen et al et al, 2000) (see Method). Global , 2000) (see Method). Global functioning and total, positive and negative functioning and total, positive and negative PANSS psychopathology all materially PANSS psychopathology all materially improved between presentation and 4-year improved between presentation and 4-year follow-up (Table 1) . follow-up (Table 1) .
Remission at 4-year follow-up Remission at 4-year follow-up
A stepwise multiple logistic regression A stepwise multiple logistic regression model ( model (w w 2 2 ¼7.3, 7.3, P P5 50.01), including gender, 0.01), including gender, diagnosis, age at onset, years in education, diagnosis, age at onset, years in education, PSA1 score, duration of untreated psycho-PSA1 score, duration of untreated psychosis, prodrome and social withdrawal indisis, prodrome and social withdrawal indicated that remission was associated with cated that remission was associated with only gender (female) ( only gender (female) (b b¼1.27, s.e.
1.27, s.e.¼0.5, 0.5, P P¼0.01; Exp 0.01; Exp b b¼3.5, 95% CI 1.3 to 9.3) 3.5, 95% CI 1.3 to 9.3) with a trend effect for a shorter duration, with a trend effect for a shorter duration, P P¼0.08. Among the 82 participants with 0.08. Among the 82 participants with schizophrenia or schizophreniform disorder schizophrenia or schizophreniform disorder 53.7% were in remission. Stepwise multiple 53.7% were in remission. Stepwise multiple regression ( regression (w w 2 2 ¼6.5, 6.5, P P¼0.01), including the 0.01), including the same variables apart from diagnosis, indisame variables apart from diagnosis, indicated that remission was associated with a cated that remission was associated with a shorter duration ( shorter duration (b b¼0.37, 0.37, P P¼0.02; Exp 0.02; Exp b b¼1.4, 95% CI 1.08 to 1.93), with a trend 1.4, 95% CI 1.08 to 1.93), with a trend effect for a shorter prodrome, effect for a shorter prodrome, P P¼0.07 and 0.07 and female gender, female gender, P P¼0.07. 0.07.
Global functioning Global functioning at 4-year follow-up at 4-year follow-up
For the 132 participants, lower GAF score For the 132 participants, lower GAF score at 4-year follow-up (GAF4) was associated at 4-year follow-up (GAF4) was associated with increasing duration of untreated psywith increasing duration of untreated psychosis ( chosis (r r¼0.35, 0.35, P P5 50.001), increasing dura-0.001), increasing duration of untreated illness ( tion of untreated illness (r r¼0.35, 0.35, P P¼0.001) 0.001) and earlier age at onset of psychosis and earlier age at onset of psychosis ( (r r¼0.24, 0.24, P P5 50.01), but not with length of 0.01), but not with length of prodrome, years in education or PSA1 prodrome, years in education or PSA1 scores. On confining analysis to those 82 scores. On confining analysis to those 82 patients with schizophrenia or schizopatients with schizophrenia or schizophreniform disorder, lower GAF4 score phreniform disorder, lower GAF4 score was associated with increasing duration of was associated with increasing duration of untreated psychosis ( untreated psychosis (r r¼7 70.43, 0.43, P P5 50.001), 0.001), increasing duration of untreated illness increasing duration of untreated illness ( (r r¼7 70.33, 0.33, P P¼0.003), fewer years of edu-0.003), fewer years of education ( cation (r r¼0.30, 0.30, P P5 50.01) and earlier age 0.01) and earlier age at onset of psychosis ( at onset of psychosis (r r¼0.27, 0.27, P P5 50.01), 0.01), but not with length of prodrome or PSA1 but not with length of prodrome or PSA1 score. score.
In a stepwise multiple linear regression In a stepwise multiple linear regression model ( model (F F¼14.8, 14.8, P P5 50.001), controlling for 0.001), controlling for GAF score at presentation (GAF1), diag-GAF score at presentation (GAF1), diagnosis, gender, age at onset of psychotic nosis, gender, age at onset of psychotic symptoms, social withdrawal at presentasymptoms, social withdrawal at presentation and prodromal length, worse GAF tion and prodromal length, worse GAF score at 4-year follow-up (GAF4) was assoscore at 4-year follow-up (GAF4) was associated with longer duration of untreated ciated with longer duration of untreated psychosis, male gender and social withpsychosis, male gender and social withdrawal (Table 2 ). The unstandardised codrawal ( Table 2 ). The unstandardised coefficients indicated that a unit increase in efficients indicated that a unit increase in duration (log-transformed) resulted in reduration (log-transformed) resulted in reduction in GAF4 scores of 5.5. We repeated duction in GAF4 scores of 5.5. We repeated the analysis substituting duration of unthe analysis substituting duration of untreated illness for duration of untreated treated illness for duration of untreated psychosis, and found the results practically psychosis, and found the results practically unchanged. We also examined the relationunchanged. We also examined the relationship of duration of untreated psychosis ship of duration of untreated psychosis with GAF4 score by calculating effect sizes. with GAF4 score by calculating effect sizes. Duration data were divided by median Duration data were divided by median score into short-and long-duration groups. score into short-and long-duration groups. The effect size for duration on GAF4 outThe effect size for duration on GAF4 outcome was come was 7 70.59 (moderate); in practice, 0.59 (moderate); in practice, this implies that 73% of participants in this implies that 73% of participants in the short-duration group would have a the short-duration group would have a GAF4 score higher than the mean GAF4 GAF4 score higher than the mean GAF4 score of the long-duration group. On score of the long-duration group. On confining analysis to those participants confining analysis to those participants with schizophrenia or schizophreniform with schizophrenia or schizophreniform disorder, and controlling for gender, age disorder, and controlling for gender, age at onset, years in education, scores at preat onset, years in education, scores at presentation and prodrome, stepwise multiple sentation and prodrome, stepwise multiple regression ( regression (F F¼11.6, 11.6, P P5 50.001) indicated 0.001) indicated GAF4 score to be associated with duration GAF4 score to be associated with duration of untreated psychosis, gender and years in of untreated psychosis, gender and years in education. GAF4 scores were reduced by education. GAF4 scores were reduced by 7.8 points for each unit increase in dura-7.8 points for each unit increase in duration. We repeated the analysis substituting tion. We repeated the analysis substituting duration of untreated illness and found duration of untreated illness and found the effect to be weaker but nonetheless sigthe effect to be weaker but nonetheless significant ( Table 2 ). The effect size for duranificant ( Table 2 ). The effect size for duration of untreated psychosis on GAF4 tion of untreated psychosis on GAF4 outcome was outcome was 7 70.65 (moderate), implying 0.65 (moderate), implying that 76% of people in the short-duration that 76% of people in the short-duration group would have a GAF4 score higher group would have a GAF4 score higher than the mean GAF4 score of the longthan the mean GAF4 score of the longduration group. duration group.
Psychopathology at 4-year Psychopathology at 4-year follow-up follow-up Among all 129 participants, higher PANSSAmong all 129 participants, higher PANSSpositive score at 4-year follow-up positive score at 4-year follow-up (PANSS4-POS) was associated with in-(PANSS4-POS) was associated with increasing duration of untreated psychoses creasing duration of untreated psychoses ( (r r¼0.29, 0.29, P P5 50.01), increasing duration of 0.01), increasing duration of untreated illness ( untreated illness (r r¼0.20, 0.20, P P¼0.03) and 0.03) and with earlier age at onset ( with earlier age at onset (r r¼0.23, 0.23, P P5 50.01), but not with length of prodrome, 0.01), but not with length of prodrome, years in education or PSA1 score; on conyears in education or PSA1 score; on confining the analysis to those 82 participants fining the analysis to those 82 participants with schizophrenia or schizophreniform with schizophrenia or schizophreniform disorder, higher PANSS4-POS score was disorder, higher PANSS4-POS score was associated with increasing duration of associated with increasing duration of psychosis ( psychosis (r r¼0.32, 0.32, P P5 50.01), but not with 0.01), but not with age at onset, length of prodrome, years in age at onset, length of prodrome, years in education or PSA1 score. education or PSA1 score.
In a stepwise multiple linear regression In a stepwise multiple linear regression model ( model (F F¼8.3, 8.3 , P P5 50.001), controlling for 0.001), controlling for PANSS-POS score at presentation PANSS-POS score at presentation (PANSS1-POS), diagnosis, gender, age at (PANSS1-POS), diagnosis, gender, age at onset of psychotic symptoms, prodromal onset of psychotic symptoms, prodromal length and social withdrawal, the length and social withdrawal, the PANSS4-POS score was associated with PANSS4-POS score was associated with gender and duration of untreated psychosis gender and duration of untreated psychosis (Table 3 ). The effect size for duration on (Table 3 ). The effect size for duration on PANSS4-POS was 0.58 (moderate), PANSS4-POS was 0.58 (moderate), implying that 73% of people in the shortimplying that 73% of people in the shortduration group would have a PANSS4-duration group would have a PANSS4-POS outcome score lower than the mean POS outcome score lower than the mean PANSS4-POS score of the long-duration PANSS4-POS score of the long-duration group. When we substituted illness for group. When we substituted illness for psychosis, this did not make a significant psychosis, this did not make a significant contribution to the model. On confining contribution to the model. On confining analyses to those participants with schizoanalyses to those participants with schizophrenia or schizophreniform disorder, stepphrenia or schizophreniform disorder, stepwise multiple regression ( wise multiple regression (F F¼7.0, 7.0, P P¼0.002) 0.002) indicated a stronger effect for psychosis. indicated a stronger effect for psychosis. Each unit increment in duration of unEach unit increment in duration of untreated psychosis resulted in an increase of treated psychosis resulted in an increase of 1.9 in PANSS4-POS scores. A repeat model 1.9 in PANSS4-POS scores. A repeat model using illness instead of psychosis demonusing illness instead of psychosis demonstrated that duration of untreated illness strated that duration of untreated illness 2 3 7 2 3 7 Adj., adjusted; s.e., standard error; DUP, duration of Adj., adjusted; s.e., standard error; DUP, duration of untreated psychosis; DUI, duration of untreated illness untreated psychosis; DUI, duration of untreated illness (substituted for DUP); GAF, global assessment of (substituted for DUP); GAF, global assessment of function score; GAF1, GAF score at presentation. function score; GAF1, GAF score at presentation. made a smaller but significant contribution made a smaller but significant contribution to the model (Table 3 ). The effect size for to the model (Table 3 ). The effect size for duration of untreated psychosis on duration of untreated psychosis on PANSS4-POS outcome was 0.73 (moder-PANSS4-POS outcome was 0.73 (moderate), implying that 76% of people in the ate), implying that 76% of people in the short-duration group would have a short-duration group would have a PANSS4-POS outcome score lower PANSS4-POS outcome score lower than the mean PANSS4-POS score of the than the mean PANSS4-POS score of the long-duration group. long-duration group. Among the 129 participants, higher Among the 129 participants, higher PANSS-negative score at 4-year follow-up PANSS-negative score at 4-year follow-up (PANSS4-NEG) was associated with in-(PANSS4-NEG) was associated with increasing duration of untreated psychosis creasing duration of untreated psychosis ( (r r¼0.29, 0.29, P P5 50.05), increasing duration of 0.05), increasing duration of untreated illness ( untreated illness (r r¼0.27, 0.27, P P¼0.003), fewer 0.003), fewer years in education ( years in education (r r¼7 70.18, 0.18, P P5 50.05), 0.05), younger age at onset ( younger age at onset (r r¼7 70.19, 0.19, P P5 50.05) 0.05) and higher or worse PSA1 score ( and higher or worse PSA1 score (r r¼0.29, 0.29, P P5 50.01), but not with length of prodrome; 0.01), but not with length of prodrome; on confining analyses to those 82 paron confining analyses to those 82 participants with schizophrenia or schizoticipants with schizophrenia or schizophreniform disorder, higher PANSS4-NEG phreniform disorder, higher PANSS4-NEG score was associated similarly with inscore was associated similarly with increasing duration of untreated psychosis creasing duration of untreated psychosis ( (r r¼0.32, 0.32, P P5 50.01), fewer years in education 0.01), fewer years in education ( (r r¼7 70.30, 0.30, P P5 50.01), younger age at onset 0.01), younger age at onset ( (r r¼7 70.25, 0.25, P P5 50.05) and higher or worse 0.05) and higher or worse PSA1 score ( PSA1 score (r r¼0.26, 0.26, P P5 50.05), but not with 0.05), but not with length of untreated prodrome ( length of untreated prodrome (r r¼0.07). 0.07).
Stepwise multiple linear regression Stepwise multiple linear regression ( (F F¼17.0, 17.0, P P5 50.001), including PANSS-0.001), including PANSS-NEG score at presentation (PANSS1-NEG score at presentation (PANSS1-NEG), diagnosis, gender, age at onset of NEG), diagnosis, gender, age at onset of psychotic symptoms, educational years, psychotic symptoms, educational years, PSA1, prodromal length and social PSA1, prodromal length and social withdrawal, PANSS4-NEG score was assowithdrawal, PANSS4-NEG score was associated with PANSS1-NEG, years in educiated with PANSS1-NEG, years in education and duration of untreated psychosis cation and duration of untreated psychosis (Table 4) ; the effect size for duration on (Table 4) ; the effect size for duration on PANSS4-NEG was 0.37 (small), implying PANSS4-NEG was 0.37 (small), implying that 66% of people in the short-duration that 66% of people in the short-duration group would have a PANSS4-NEG score group would have a PANSS4-NEG score lower than the mean PANSS4-NEG score lower than the mean PANSS4-NEG score of the long-duration group. On confining of the long-duration group. On confining analyses to those participants with schizoanalyses to those participants with schizophrenia or schizophreniform disorder, stepphrenia or schizophreniform disorder, stepwise multiple regression ( wise multiple regression (F F¼17.0, 17.0, P P5 50.001) 0.001) including PANSS1-NEG, gender, years in including PANSS1-NEG, gender, years in education, duration of untreated psychosis education, duration of untreated psychosis and prodrome, indicated PANSS4-NEG and prodrome, indicated PANSS4-NEG score to be associated with PANSS1-NEG, score to be associated with PANSS1-NEG, years in education and duration (Table 4) . years in education and duration (Table 4) . The effect size for duration on PANSS4-The effect size for duration on PANSS4-NEG was 0.35 (small), implying that 66% NEG was 0.35 (small), implying that 66% of people in the short-duration group of people in the short-duration group would have a PANSS4-NEG score lower would have a PANSS4-NEG score lower than the mean PANSS4-NEG score of the than the mean PANSS4-NEG score of the long-duration group. Duration of untreated long-duration group. Duration of untreated illness made no independent contribution illness made no independent contribution to the model. to the model.
DISCUSSION DISCUSSION
This study concerns a large, prospectively This study concerns a large, prospectively ascertained, epidemiologically complete ascertained, epidemiologically complete and hence representative population of and hence representative population of people experiencing their first psychotic people experiencing their first psychotic episode. We analysed the association of episode. We analysed the association of duration of untreated psychosis with both duration of untreated psychosis with both functional and psychological outcome over functional and psychological outcome over 4-year follow-up across diagnoses. The 4-year follow-up across diagnoses. The principal finding was that increasing duraprincipal finding was that increasing duration was independently associated with tion was independently associated with reduced likelihood of remission, poorer reduced likelihood of remission, poorer functional outcome and increasing psychofunctional outcome and increasing psychopathology at 4 years. The issue of whether pathology at 4 years. The issue of whether the effect of duration extends beyond relathe effect of duration extends beyond relatively short-term follow-up is critical, given tively short-term follow-up is critical, given that most (Wiermsa that most (Wiermsa et al et al, 1998; Robinson , 1998; Robinson et al et al, 1999; Craig , 1999 (2001) have postulated that the predictive power have postulated that the predictive power of initial duration of untreated psychosis of initial duration of untreated psychosis may weaken over time. However, they may weaken over time. However, they suggest that indices of outcome other than suggest that indices of outcome other than remission and relapse should be examined. remission and relapse should be examined.
Strengths Strengths
One of the strengths of this study is the One of the strengths of this study is the representativeness of the sample (Friis representativeness of the sample (Friis et et al al, 2003) . This was achieved by sourcing , 2003). This was achieved by sourcing the sample from a geographically defined the sample from a geographically defined area, including consecutive out-patients as area, including consecutive out-patients as well as in-patients, and not applying excluwell as in-patients, and not applying exclusion criteria relating to age or substance sion criteria relating to age or substance misuse. Furthermore, the initial measures misuse. Furthermore, the initial measures were an integral part of a comprehensive were an integral part of a comprehensive clinical assessment and included all cases clinical assessment and included all cases of psychosis within the catchment area reof psychosis within the catchment area referred for assessment. Although there was ferred for assessment. Although there was a degree of sample attrition during the inia degree of sample attrition during the initial and follow-up assessments, this was less tial and follow-up assessments, this was less than 30%. All the follow-up interviews than 30%. All the follow-up interviews were conducted face to face by an interwere conducted face to face by an interviewer, and did not rely solely on chart viewer, and did not rely solely on chart information or telephone interviews. The information or telephone interviews. The researcher who conducted the follow-up researcher who conducted the follow-up was masked to both duration and inception was masked to both duration and inception ratings. ratings.
As many of the negative studies have reAs many of the negative studies have related to samples with schizophrenia only lated to samples with schizophrenia only (Robinson (Robinson et al et al, 1999; Barnes , 1999; Barnes et al et al, 2000; , 2000 ; Ho e Ho et al t al, 2000), we analysed schizophrenia , 2000), we analysed schizophrenia and schizophreniform disorder separately and schizophreniform disorder separately and found some difference. However, apart and found some difference. However, apart from negative symptoms, the effect of durafrom negative symptoms, the effect of duration of untreated psychosis mostly became tion of untreated psychosis mostly became stronger. Nonetheless, the differences stronger. Nonetheless, the differences between schizophrenia and schizophrenibetween schizophrenia and schizophreniform disorder and the total group suggest form disorder and the total group suggest that the results from a mixed first-episode that the results from a mixed first-episode sample may not translate to individual sample may not translate to individual diagnostic categories. We dealt with the diagnostic categories. We dealt with the skewed duration data and controlled for skewed duration data and controlled for both confounders, and values of a partiboth confounders, and values of a particular outcome variable at presentation cular outcome variable at presentation (Norman & Malla, 2001; Friis (Norman & Malla, 2001; Friis et al et al, , 2003) . We broadened the outcome vari-2003). We broadened the outcome variables beyond remission and relapse, partiables beyond remission and relapse, particularly as another study has shown that cularly as another study has shown that duration may have a selective influence on duration may have a selective influence on some aspects of outcome but not others some aspects of outcome but not others (Malla (Malla et al et al, 2002) . , 2002).
Limitations Limitations
Limitations to the study include the fact Limitations to the study include the fact that the sample size did not permit examinthat the sample size did not permit examination of individual diagnostic categories ation of individual diagnostic categories other than schizophrenia and schizophreniother than schizophrenia and schizophreniform disorder, only three dimensions of form disorder, only three dimensions of outcome were assessed and the results are outcome were assessed and the results are at an associative rather than causative level at an associative rather than causative level and did not involve the manipulation of the and did not involve the manipulation of the duration variable. No cases of schizoaffecduration variable. No cases of schizoaffective disorder or brief psychotic disorder tive disorder or brief psychotic disorder were diagnosed at inception. At 4-year were diagnosed at inception. At 4-year follow-up, when the SCID was repeated follow-up, when the SCID was repeated by an investigator masked to the original by an investigator masked to the original diagnosis, three cases of schizophrenia were diagnosis, three cases of schizophrenia were subsequently diagnosed with schizoaffecsubsequently diagnosed with schizoaffective disorder (Whitty tive disorder (Whitty et al et al, 2005) . Nonethe-, 2005) . Nonetheless, the paucity of these cases at inception less, the paucity of these cases at inception remains a cause of concern. remains a cause of concern.
2 3 8 2 3 8 Another weakness relates to the meaAnother weakness relates to the measurement of the prodrome and its inclusion surement of the prodrome and its inclusion in the statistical analyses. It is difficult to in the statistical analyses. It is difficult to measure the prodrome reliably, and one measure the prodrome reliably, and one could argue that it should be excluded from could argue that it should be excluded from the data. However, given evolving interest the data. However, given evolving interest in, but concerns over, the reliable measurein, but concerns over, the reliable measurement of duration of untreated illness as disment of duration of untreated illness as distinct from untreated psychosis, these are tinct from untreated psychosis, these are offered as exploratory analyses to stimulate offered as exploratory analyses to stimulate further work in a controversial area. further work in a controversial area.
Level of functioning Level of functioning and negative symptoms and negative symptoms
This study showed that duration of unThis study showed that duration of untreated psychosis is associated with global treated psychosis is associated with global functioning. These findings are broadly functioning. These findings are broadly consistent with the results from an early consistent with the results from an early intervention project in Norway that intervention project in Norway that showed that the early-detection group had showed that the early-detection group had sustained improvement in global funcsustained improvement in global functioning but not in positive symptoms at tioning but not in positive symptoms at 3-month follow-up (Melle 3-month follow-up (Melle et al et al, 2004) . , 2004). Thus duration of untreated psychosis may Thus duration of untreated psychosis may have a selective effect, influencing some dihave a selective effect, influencing some dimensions of outcome more than others mensions of outcome more than others (Malla (Malla et al et al, 2002) . , 2002). Global negative symptoms at presentaGlobal negative symptoms at presentation emerged as the best predictor of the tion emerged as the best predictor of the level of negative symptoms at 4 years. level of negative symptoms at 4 years. However, contrary to other findings However, contrary to other findings (Wiermsa (Wiermsa et al et al, 1998; Craig , 1998; Craig et al et al, 2000; , 2000; Larsen Larsen et al et al, 2000; Malla , 2000; Malla et al et al, 2002) , we , 2002), we found that duration of untreated psychosis found that duration of untreated psychosis made a small contribution to the model in made a small contribution to the model in the total group. Unlike Harrigan the total group. Unlike Harrigan et al et al (2003), we did not find a major influence (2003), we did not find a major influence for duration of untreated psychoses in the for duration of untreated psychoses in the schizophrenia and schizophreniform disorschizophrenia and schizophreniform disorder group. Indeed, the direction was der group. Indeed, the direction was opposite to that which we had anticipated. opposite to that which we had anticipated. Analysis of the data using effect sizes Analysis of the data using effect sizes (which are less influenced by sample size) (which are less influenced by sample size) demonstrated small effect sizes for duration demonstrated small effect sizes for duration of untreated psychosis in the total group of untreated psychosis in the total group and the schizophrenia and schizophreniand the schizophrenia and schizophreniform disorder group. Negative symptoms form disorder group. Negative symptoms tend to be less responsive to pharmacotend to be less responsive to pharmacological intervention, and it remains to be logical intervention, and it remains to be seen whether medication and intensive seen whether medication and intensive psychosocial rehabilitation in combination psychosocial rehabilitation in combination with early intervention will have more of with early intervention will have more of an impact in tackling negative symptoms. an impact in tackling negative symptoms.
Keshavan Keshavan et al et al (2003) have recently (2003) have recently highlighted the importance of considering highlighted the importance of considering the effect of duration of untreated illness the effect of duration of untreated illness on outcome. In their sample of 101 individon outcome. In their sample of 101 individuals with a first episode of psychosis, they uals with a first episode of psychosis, they found that the duration of untreated illness found that the duration of untreated illness was a stronger predictor of 2-year outcome was a stronger predictor of 2-year outcome than that of psychosis. However, these than that of psychosis. However, these effects were marginal. In this study, the effects were marginal. In this study, the duration of untreated illness was associated duration of untreated illness was associated with global functioning at 4 years and with with global functioning at 4 years and with positive symptoms in the schizophrenia and positive symptoms in the schizophrenia and schizophreniform disorder group, but had schizophreniform disorder group, but had no effect on negative symptoms. The durano effect on negative symptoms. The duration of the prodrome was not significantly tion of the prodrome was not significantly associated with any of the outcome variassociated with any of the outcome variables, apart from negative symptoms in ables, apart from negative symptoms in the schizophrenia and schizophreniform the schizophrenia and schizophreniform group. Other studies have found that the group. Other studies have found that the prodrome did not influence time to reprodrome did not influence time to remission or level of remission (Loebel mission or level of remission (Loebel et al et al, , 1992; Malla 1992; Malla et al et al, 2002) , negative symp-, 2002), negative symptoms (Malla toms (Malla et al et al, 2002; Harrigan , 2002; Harrigan et al et al, , 2003) , but had small effects on positive 2003), but had small effects on positive symptoms (Malla symptoms (Malla et al et al, 2002) and a sig-, 2002) and a significant association with functional outnificant association with functional outcome (Harrigan come (Harrigan et al et al, 2003) . It is possible , 2003). It is possible that the duration of the prodrome phase that the duration of the prodrome phase may have an independent effect on outmay have an independent effect on outcome, but our results suggest a more robust come, but our results suggest a more robust duration of untreated psychosis. duration of untreated psychosis.
Early intervention Early intervention
The association between duration of unThe association between duration of untreated psychosis and functional outcome treated psychosis and functional outcome supports the likely benefits of early intersupports the likely benefits of early intervention in psychosis. Nonetheless, successvention in psychosis. Nonetheless, successful reduction of the duration may not be ful reduction of the duration may not be as easy as it sounds. In addition to a speciaas easy as it sounds. In addition to a specialist rapid-access programme, most early inlist rapid-access programme, most early intervention services include an educational tervention services include an educational component that aims to increase the ability component that aims to increase the ability of general practitioners to recognise the of general practitioners to recognise the early stages of psychosis. However, with early stages of psychosis. However, with the increased availability of counselling the increased availability of counselling practices and alternative medical services, practices and alternative medical services, it will be important to find out whether in it will be important to find out whether in fact general practitioners are usually the fact general practitioners are usually the first port of call in the early stages of a first port of call in the early stages of a psychotic illness. Examining pathways to psychotic illness. Examining pathways to care available to such individuals may procare available to such individuals may provide these answers. Furthermore, a clearer vide these answers. Furthermore, a clearer understanding of the sociocultural factors understanding of the sociocultural factors that influence disease recognition, particuthat influence disease recognition, particularly among family members, may also be larly among family members, may also be helpful. helpful. 
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